FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794173683> ?p ?o ?g. }

• W2794173683 endingPage "791" @default.
• W2794173683 startingPage "780" @default.
• W2794173683 abstract "Major Objectives: To review the efficacy, safety, and economics of sarilumab, an interleukin-6 (IL-6) receptor antagonist, in the treatment of rheumatoid arthritis (RA). Data Sources: PubMed (1966 to January 2018), Clinicaltrials.gov (January 2018), and Scopus (1970 to January 2018) were searched using sarilumab, Kevzara, REGN88, and SAR153191. Study Selection and Data Extraction: Human studies published in peer-reviewed publications in English were the primary sources for efficacy and safety. Data Synthesis: Data from randomized, double-blind, controlled, published clinical studies weeks demonstrated statistically significantly higher American College of Rheumatology (ACR) 20, ACR50, and Disease Activity Score-28 (DAS28) remission response rates and improvements in DAS28 and Health Assessment Questionnaire–Disability Index scores for sarilumab monotherapy versus adalimumab monotherapy (P < 0.05) and for sarilumab versus placebo in patients receiving methotrexate or other conventional synthetic disease-modifying antirheumatic drugs (DMARDs); P < 0.05. The ACR20 and ACR50 response rates were, respectively, 56-72% and 35-46% for sarilumab, 58% and 30% for adalimumab, and 33-34% and 15-18% for placebo. DAS28 remission rates were 20-34% for sarilumab, 7% for adalimumab, and 7-10% for placebo. Sarilumab has a higher risk for neutropenia than tocilizumab, the other IL-6 inhibitor, but a lower risk for dyslipidemia, injection site reactions, and gastrointestinal perforation. The acquisition costs of sarilumab are expected to be similar to those of most other biologic DMARDs. Conclusion: Sarilumab is an alternative to biologic DMARDs or targeted synthetic DMARDs in patients with moderate to severely active RA who have not responded adequately to prior conventional synthetic DMARDs or tumor necrosis factor-α inhibitors." @default.
• W2794173683 created "2018-03-29" @default.
• W2794173683 creator A5045274671 @default.
• W2794173683 creator A5046373336 @default.
• W2794173683 creator A5067667590 @default.
• W2794173683 creator A5072308791 @default.
• W2794173683 creator A5089743019 @default.
• W2794173683 date "2018-02-26" @default.
• W2794173683 modified "2023-10-10" @default.
• W2794173683 title "Sarilumab: Review of a Second IL-6 Receptor Antagonist Indicated for the Treatment of Rheumatoid Arthritis" @default.
• W2794173683 cites W1566149917 @default.
• W2794173683 cites W1586828706 @default.
• W2794173683 cites W1608831349 @default.
• W2794173683 cites W2012942026 @default.
• W2794173683 cites W2068270744 @default.
• W2794173683 cites W2069019419 @default.
• W2794173683 cites W2102207725 @default.
• W2794173683 cites W2104917657 @default.
• W2794173683 cites W2110463517 @default.
• W2794173683 cites W2120393706 @default.
• W2794173683 cites W2126525702 @default.
• W2794173683 cites W2134390470 @default.
• W2794173683 cites W2147810684 @default.
• W2794173683 cites W2168704263 @default.
• W2794173683 cites W2211552606 @default.
• W2794173683 cites W2293692550 @default.
• W2794173683 cites W2314383248 @default.
• W2794173683 cites W2320345884 @default.
• W2794173683 cites W2334312828 @default.
• W2794173683 cites W2513662764 @default.
• W2794173683 cites W2527818415 @default.
• W2794173683 cites W2529784452 @default.
• W2794173683 cites W2530829879 @default.
• W2794173683 cites W2549509332 @default.
• W2794173683 cites W2549844032 @default.
• W2794173683 cites W2557016092 @default.
• W2794173683 cites W2564164047 @default.
• W2794173683 cites W2588847707 @default.
• W2794173683 cites W2593835974 @default.
• W2794173683 cites W2596931952 @default.
• W2794173683 cites W2600699247 @default.
• W2794173683 cites W2623617647 @default.
• W2794173683 cites W2971217817 @default.
• W2794173683 cites W592943408 @default.
• W2794173683 doi "https://doi.org/10.1177/1060028018761599" @default.
• W2794173683 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29482351" @default.
• W2794173683 hasPublicationYear "2018" @default.
• W2794173683 type Work @default.
• W2794173683 sameAs 2794173683 @default.
• W2794173683 citedByCount "38" @default.
• W2794173683 countsByYear W27941736832018 @default.
• W2794173683 countsByYear W27941736832019 @default.
• W2794173683 countsByYear W27941736832020 @default.
• W2794173683 countsByYear W27941736832021 @default.
• W2794173683 countsByYear W27941736832022 @default.
• W2794173683 countsByYear W27941736832023 @default.
• W2794173683 crossrefType "journal-article" @default.
• W2794173683 hasAuthorship W2794173683A5045274671 @default.
• W2794173683 hasAuthorship W2794173683A5046373336 @default.
• W2794173683 hasAuthorship W2794173683A5067667590 @default.
• W2794173683 hasAuthorship W2794173683A5072308791 @default.
• W2794173683 hasAuthorship W2794173683A5089743019 @default.
• W2794173683 hasConcept C126322002 @default.
• W2794173683 hasConcept C142724271 @default.
• W2794173683 hasConcept C197934379 @default.
• W2794173683 hasConcept C204787440 @default.
• W2794173683 hasConcept C27081682 @default.
• W2794173683 hasConcept C2777178219 @default.
• W2794173683 hasConcept C2777575956 @default.
• W2794173683 hasConcept C2780132546 @default.
• W2794173683 hasConcept C71924100 @default.
• W2794173683 hasConceptScore W2794173683C126322002 @default.
• W2794173683 hasConceptScore W2794173683C142724271 @default.
• W2794173683 hasConceptScore W2794173683C197934379 @default.
• W2794173683 hasConceptScore W2794173683C204787440 @default.
• W2794173683 hasConceptScore W2794173683C27081682 @default.
• W2794173683 hasConceptScore W2794173683C2777178219 @default.
• W2794173683 hasConceptScore W2794173683C2777575956 @default.
• W2794173683 hasConceptScore W2794173683C2780132546 @default.
• W2794173683 hasConceptScore W2794173683C71924100 @default.
• W2794173683 hasIssue "8" @default.
• W2794173683 hasLocation W27941736831 @default.
• W2794173683 hasLocation W27941736832 @default.
• W2794173683 hasOpenAccess W2794173683 @default.
• W2794173683 hasPrimaryLocation W27941736831 @default.
• W2794173683 hasRelatedWork W1904221345 @default.
• W2794173683 hasRelatedWork W1968608851 @default.
• W2794173683 hasRelatedWork W1989137555 @default.
• W2794173683 hasRelatedWork W200640354 @default.
• W2794173683 hasRelatedWork W2007965596 @default.
• W2794173683 hasRelatedWork W2012491046 @default.
• W2794173683 hasRelatedWork W2042304386 @default.
• W2794173683 hasRelatedWork W2100569870 @default.
• W2794173683 hasRelatedWork W2468197021 @default.
• W2794173683 hasRelatedWork W3085754431 @default.
• W2794173683 hasVolume "52" @default.
• W2794173683 isParatext "false" @default.
• W2794173683 isRetracted "false" @default.

• next